INKON Life Technology Co., Ltd.

INKON Life Technology Co., Ltd. is a health technology company listed on the ChiNext board of the Shenzhen Stock Exchange since 2010. The company focuses on creating a comprehensive ecosystem for medical services, including pre-treatment, diagnosis, treatment, and rehabilitation, with a strong emphasis on oncology and the integration of artificial intelligence in healthcare. The company's operations are divided into two main business lines: medical services and medical devices. In medical services, INKON Life specializes in oncology, providing full-cycle treatment and managing several hospitals and nursing homes, including recognized institutions like Sichuan Friendship Hospital. Its medical devices segment emphasizes high-end product development and international market expansion, leveraging AI technology to enhance product offerings. The company maintains a diverse product portfolio and has established a robust digital service capability, aiming to improve efficiency and quality in healthcare delivery.

(1) Medical Services Yingkang Life, with its "strong specialists and strong generalists" model, provides comprehensive medical services focused on tumor treatment across the entire disease cycle. Its integrated "hospital + platform + ecosystem" approach has delivered significant results. As of the reporting date, the company operated and managed 10 hospitals and nursing homes, including top-tier institutions such as Sichuan Friendship Hospital and Suzhou Guangci Tumor Hospital. Several of its hospitals have achieved "5-star 3A" certification or been listed on relevant rankings, establishing a full-scenario medical service industry pattern that spans serious medical treatment, critical illness rehabilitation, and nursing elderly care. Hospitals: First, the company strengthened its specialties by focusing on tumor services. It enhanced its capabilities in the entire process of tumor prevention, diagnosis, treatment, and rehabilitation, established a full-scenario management system to address patient pain points, increased tumor-related revenue, and secured recognition of Friendship Hospital as a pilot unit. Second, it reinforced its technological capabilities by introducing new technologies, launching new projects, and adding new equipment, which enabled multiple innovations and "first-ever" surgical achievements at national and provincial levels. Third, it bolstered talent development through the "three-specializations" strategy and an entrepreneurship partner mechanism to boost the capabilities of medical professionals. Ecosystem: By leveraging its ecosystem advantages to enhance service capabilities, the company seized the opportunity of the silver economy and developed its nursing and elderly care business. It completed the entrustment of several related institutions, thereby closing the industrial loop and strengthening its capabilities. The company also clarified the positioning of regional medical centers, increased user stickiness through medical consortiums, and enhanced hospital brand influence by conducting charitable activities at schools, rural areas, communities, and nursing homes. Platform: Since 2021, it has laid out "AI + healthcare", gaining a first-mover advantage. It has built a full-scenario smart interaction engine for patients. Through cooperation with leading firms like United Imaging and iFlytek, it has improved AI technology and diagnostic services. Its hospitals have applied AI-enabled equipment and systems to raise diagnostic efficiency. (2) Medical Devices High R & D Investment and Innovation: R & D investment was stable, with a 39% CAGR over three years. By integrating resources and optimizing the R & D process, the company has achieved remarkable results. The application of AI technology in medical devices is gradually being implemented. Through industry-academia-research collaboration with prestigious universities and institutions, knowledge sharing and technological exchange are promoted, accelerating the transformation of R & D achievements. Rich Product System: The company has a diverse product portfolio covering four major scenarios - radiotherapy, life support, image enhancement, and chronic disease treatment. It provides comprehensive solutions for key tumor-related scenarios and equipment. Full-Scenario Digitalization Service Capability: The company focuses on the stability, safety, and digitalization of medical devices to build scenario-based service capabilities. Its subsidiary, Tongdayi, stands out. With its digital technology, it solves information silo problems and drives the digital transformation of the medical industry. Advanced Quality and Smart Manufacturing System: The company adheres to product quality standards, strictly implementing the ISO13485 standard and quality management regulations for medical device production. It continuously optimizes management processes and, leveraging Haier Group's top-notch lean manufacturing system, enhances production processes, supply chain capabilities, and production management to build an advanced smart manufacturing system for Yingkang Life's medical devices.